Crossmark

Uso de la polipíldora cardiovascular 40 mg en prevención cardiovascular secundaria

Crossref DOI link: https://doi.org/10.1016/j.arteri.2018.04.004

Published Print: 2018-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Marzal, Domingo

Rodríguez Padial, Luis

Arnáiz, Joan-Albert

Castro, Almudena

Cosín, Juan

Lekuona, Iñaki

Guijarro, Carlos
License Information

Text and Data Mining valid from 2018-09-01
More Information

This article is maintained by: Elsevier

Article Title: Uso de la polipíldora cardiovascular 40mg en prevención cardiovascular secundaria

Journal Title: Clínica e Investigación en Arteriosclerosis

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arteri.2018.04.004

Content Type: article

Copyright: © 2018 Sociedad Española de Arteriosclerosis. Published by Elsevier España, S.L.U. All rights reserved.